Repurposing of antiparasitic drugs for Candidate SARS-CoV-2 Main Protease Inhibitors by combined in silico Method
2021
Преузимање 🢃
Конференцијски прилог (Објављена верзија)

Метаподаци
Приказ свих података о документуАпстракт
The SARS-CoV-2 outbreak that is spreading rapidly around the world requires urgently effective treatments. Therefore, in silico drug repurposing represents a powerful strategy to enable the acceleration of the identification of drug candidates with already known safety profiles. The SARS-CoV-2 main protease is essential for viral replication and an attractive drug target. This study used the virtual screening protocol with both long-range and short-range interactions to select candidate SARS-CoV-2 main protease inhibitors. The Informational spectrum method developed for small molecules was first applied for searching the Drugbank database of antiparasitic agents and further followed by molecular docking. After in silico screening of drug space, we propose several drugs as potential SARS-CoV-2 main protease inhibitors for further experimental testing.
Кључне речи:
SARS-CoV-2 / main protease / virtual screening / drug repurposing / antiparasiticsИзвор:
Biologia Serbica : Belgrade BioInformatics Conference : BelBi2021 : Book of Abstracts, 2021, 43, 1, 111-111Издавач:
- Department of Biology and Ecology : Faculty of Sciences University of Novi Sad
Напомена:
- Special Edition of Book of Abstracts
- Biologia Serbica : Belgrade BioInformatics Conference : 21-25 June, 2021, Vinča.
Институција/група
VinčaTY - CONF AU - Senćanski, Milan AU - Milićević, Jelena S. AU - Perović, Vladimir R. AU - Glišić, Sanja PY - 2021 UR - https://vinar.vin.bg.ac.rs/handle/123456789/11016 AB - The SARS-CoV-2 outbreak that is spreading rapidly around the world requires urgently effective treatments. Therefore, in silico drug repurposing represents a powerful strategy to enable the acceleration of the identification of drug candidates with already known safety profiles. The SARS-CoV-2 main protease is essential for viral replication and an attractive drug target. This study used the virtual screening protocol with both long-range and short-range interactions to select candidate SARS-CoV-2 main protease inhibitors. The Informational spectrum method developed for small molecules was first applied for searching the Drugbank database of antiparasitic agents and further followed by molecular docking. After in silico screening of drug space, we propose several drugs as potential SARS-CoV-2 main protease inhibitors for further experimental testing. PB - Department of Biology and Ecology : Faculty of Sciences University of Novi Sad C3 - Biologia Serbica : Belgrade BioInformatics Conference : BelBi2021 : Book of Abstracts T1 - Repurposing of antiparasitic drugs for Candidate SARS-CoV-2 Main Protease Inhibitors by combined in silico Method VL - 43 IS - 1 SP - 111 EP - 111 UR - https://hdl.handle.net/21.15107/rcub_vinar_11016 ER -
@conference{
author = "Senćanski, Milan and Milićević, Jelena S. and Perović, Vladimir R. and Glišić, Sanja",
year = "2021",
abstract = "The SARS-CoV-2 outbreak that is spreading rapidly around the world requires urgently effective treatments. Therefore, in silico drug repurposing represents a powerful strategy to enable the acceleration of the identification of drug candidates with already known safety profiles. The SARS-CoV-2 main protease is essential for viral replication and an attractive drug target. This study used the virtual screening protocol with both long-range and short-range interactions to select candidate SARS-CoV-2 main protease inhibitors. The Informational spectrum method developed for small molecules was first applied for searching the Drugbank database of antiparasitic agents and further followed by molecular docking. After in silico screening of drug space, we propose several drugs as potential SARS-CoV-2 main protease inhibitors for further experimental testing.",
publisher = "Department of Biology and Ecology : Faculty of Sciences University of Novi Sad",
journal = "Biologia Serbica : Belgrade BioInformatics Conference : BelBi2021 : Book of Abstracts",
title = "Repurposing of antiparasitic drugs for Candidate SARS-CoV-2 Main Protease Inhibitors by combined in silico Method",
volume = "43",
number = "1",
pages = "111-111",
url = "https://hdl.handle.net/21.15107/rcub_vinar_11016"
}
Senćanski, M., Milićević, J. S., Perović, V. R.,& Glišić, S.. (2021). Repurposing of antiparasitic drugs for Candidate SARS-CoV-2 Main Protease Inhibitors by combined in silico Method. in Biologia Serbica : Belgrade BioInformatics Conference : BelBi2021 : Book of Abstracts Department of Biology and Ecology : Faculty of Sciences University of Novi Sad., 43(1), 111-111. https://hdl.handle.net/21.15107/rcub_vinar_11016
Senćanski M, Milićević JS, Perović VR, Glišić S. Repurposing of antiparasitic drugs for Candidate SARS-CoV-2 Main Protease Inhibitors by combined in silico Method. in Biologia Serbica : Belgrade BioInformatics Conference : BelBi2021 : Book of Abstracts. 2021;43(1):111-111. https://hdl.handle.net/21.15107/rcub_vinar_11016 .
Senćanski, Milan, Milićević, Jelena S., Perović, Vladimir R., Glišić, Sanja, "Repurposing of antiparasitic drugs for Candidate SARS-CoV-2 Main Protease Inhibitors by combined in silico Method" in Biologia Serbica : Belgrade BioInformatics Conference : BelBi2021 : Book of Abstracts, 43, no. 1 (2021):111-111, https://hdl.handle.net/21.15107/rcub_vinar_11016 .


